Under the able guidance of Dr. Shweta Agarwal, Professor, and Principal of L.R. Institute of Pharmacy, a significant achievement has been attained with the securing of a patent titled “Single Herb Extract based topical Gel Formulation with powerful broad-spectrum anti-fungal activity and method thereof.” This groundbreaking research represents a milestone in pharmaceutical innovation, paving the way for a novel antifungal herbal gel utilizing the extract of leaves from the widely available Bush Morning Glory plant, known botanically as Ipomoea Cornea.
The research endeavor focuses on addressing the pressing need for effective antifungal treatments, particularly in the realm of topical applications. The developed product, based on the herbal extract, has shown remarkable efficacy during in-vitro antifungal studies. Its potent broad-spectrum activity against fungal pathogens underscores its potential as a valuable addition to the armamentarium against fungal infections.
One of the notable attributes of the developed gel formulation is its proven safety profile. Initiation studies conducted on rats have demonstrated that the product exhibits no signs of irritation, indicating its suitability for topical use. This aspect is crucial in ensuring patient comfort and compliance, further enhancing the product’s appeal in clinical settings.
Moreover, the method employed for the formulation of the gel is noteworthy for its practicality and cost-effectiveness. By utilizing readily available instruments and chemicals, the formulation process is streamlined, thereby reducing production costs and facilitating scalability. This aspect bodes well for the commercial viability of the invention, opening avenues for its widespread adoption and accessibility.
The significance of this patent extends beyond its scientific and technical aspects. It holds promise as a commercially viable solution for addressing resistant fungal infections, a pressing global health concern. The accessibility and affordability of the formulation method further enhance its potential impact, particularly in resource-constrained settings where fungal infections pose significant health challenges.
In summary, the patent secured by L.R. Institute of Pharmacy represents a significant leap forward in the field of pharmaceutical research and development. With its innovative approach, potent efficacy, and practical formulation method, the herbal gel holds promise as a valuable therapeutic option for combating fungal infections. Its commercialization and widespread availability stand to benefit countless individuals grappling with these debilitating conditions, underscoring the institute’s commitment to advancing healthcare through innovation and excellence.